Meeting
2013 ASCO Annual Meeting
Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors.
Authors
Katherine M. Bell-McGuinn
Memorial Sloan-Kettering Cancer Center, New York, NY
Katherine M. Bell-McGuinn , Heidi J. Gray , Gini F. Fleming , Mihaela C. Cristea , Diane M. Medina , Hao Xiong , Matthew W. Dudley , Martin Dunbar , Vincent L. Giranda , Yan Luo , Mark D. McKee , Lainie P. Martin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
DNA Repair and Apoptosis
Clinical Trial Registration Number
NCT01063816
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2584^)
DOI
10.1200/jco.2013.31.15_suppl.2584
Abstract #
2584^
Poster Bd #
7D
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A phase I study of MM-121 in combination with multiple anticancer therapies in patients with advanced solid tumors.
First Author: Monica Arnedos
Poster
2017 ASCO Annual Meeting
Phase 1/2 study of veliparib (V) combined with carboplatin (Cb) and etoposide (E) in patients (pts) with extensive-stage disease (ED) small cell lung cancer (SCLC) and other solid tumors: Phase 1 results.
First Author: Florence Atrafi
Poster
2014 ASCO Annual Meeting
A phase I and pharmacokinetic study of a weekly dosing schedule of paclitaxel injection concentrate for nano-dispersion (PICN) in patients with advanced solid tumors.
First Author: Wen Wee Ma
Poster
2012 ASCO Annual Meeting
ABT-888 (veliparib) in combination with weekly carboplatin and paclitaxel in advanced solid tumors.
First Author: Jorge Arturo Rios-Perez